ICU Medical, Inc. (ICUI) Financials

ICUI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 4.0 billion 1.9 billion
Dec. 31, 2025 4.1 billion 1.9 billion
Sept. 30, 2025 4.1 billion 2.0 billion
June 30, 2025 4.1 billion 2.0 billion

ICUI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 27.6 million 14.0 million
Dec. 31, 2025 36.0 million 13.9 million
Sept. 30, 2025 27.6 million 15.2 million
June 30, 2025 -10.8 million 14.5 million

ICUI Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 30.1 million
Dec. 31, 2025 -15.7 million
Sept. 30, 2025 -3.4 million
June 30, 2025 35.3 million

ICUI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 288.3 million 1.3 billion 45.2 million
Dec. 31, 2025 308.0 million 1.3 billion 47.7 million
Sept. 30, 2025 299.7 million 1.3 billion 50.6 million
June 30, 2025 300.0 million 1.3 billion 52.5 million

ICUI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 25.2 million
Dec. 31, 2025 24.7 million
Sept. 30, 2025 24.7 million
June 30, 2025 24.7 million

ICUI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 11.3 million 21.3 million 154.6 million -
Dec. 31, 2025 24.6 million 21.1 million 155.8 million -
Sept. 30, 2025 29.1 million 21.3 million 152.8 million -
June 30, 2025 22.0 million 21.9 million 159.4 million -

ICUI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 530.4 million 357.3 million
Dec. 31, 2025 540.3 million 338.2 million
Sept. 30, 2025 537.0 million 336.1 million
June 30, 2025 548.9 million 340.8 million

ICUI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ICUI

Price: $142.20

52 week price:
107.00
160.29

Earnings Per Share: 1.86 USD

P/E Ratio: 65.61

Exchange: NMS

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 116973

Ebitda: 23.0 million

Market Capitalization: 3.3 billion

Links: